Generic
Glimepiride + Rosiglitazone
4 brands available in the market
At a glance
Glimepiride + Rosiglitazone is a combination antidiabetic medicine used to control blood sugar in type 2 diabetes mellitus.
Description
Introduction: Glimepiride + Rosiglitazone is a combination medicine used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
How it works: Glimepiride: Initial effect to increase insulin secretion from beta cells; may also decrease rate of hepatic glucose production and increase insulin receptor sensitivity. Rosiglitazone: Lowers glucose by improving target cell response to insulin without increasing pancreatic cell secretion; activates nuclear peroxisome proliferator-activated receptor gamma, which influences the production of gene products involved in glucose and lipid metabolism.
Important Information: Take with food. Take with the first meal of the day. Do not stop without consulting your doctor. Regular blood sugar and liver function tests are recommended.
Indications
- Type 2 diabetes mellitus
Therapeutic class
Combination Oral hypoglycemic preparations
Pharmacological class
Sulfonylurea + Thiazolidinedione
Pharmacology
Glimepiride: Initial effect to increase insulin secretion from beta cells; may also decrease rate of hepatic glucose production and increase insulin receptor sensitivity. Rosiglitazone: Lowers glucose by improving target cell response to insulin without increasing pancreatic cell secretion; activates nuclear peroxisome proliferator-activated receptor gamma, which influences the production of gene products involved in glucose and lipid metabolism.
Mechanism of action
Glimepiride increases insulin secretion and Rosiglitazone improves insulin sensitivity to lower blood sugar levels.
Dosage
Adult Dose:
- Starting Dose: 1 tab (4mg/1mg) once daily with first meal of day
- Glimepiride component increased not to exceed 2 mg every 1-2 weeks
- Not to exceed 8 mg rosiglitazone/4 mg glimepiride
Elderly: 1 tab (4mg/1mg) once daily, titrate carefully
Hepatic Impairment: ALT >2.5x ULN: Do not administer
Renal Impairment: 1 tab (4mg/1mg) once daily, titrate carefully
* Use as directed by the registered physician
Administration
Oral tablet. Take with food (with the first main meal). Swallow whole, do not chew or crush.
Missed dose
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and follow your regular schedule. Do not double the dose.
Side effects
Common Side Effects:
- Hypoglycemia (low blood sugar)
- Nausea
- Taste change
- Diarrhea
- Stomach pain
- Headache
- Edema (swelling)
- Weight gain
- Blurred vision
- Bone fracture
- Respiratory tract infection
Precautions & warnings
Precautions:
- Patients with established Class III or IV heart failure is contraindicated.
- Hypoglycemia may occur - always carry sugary food or fruit juice.
- Avoid alcohol (increases hypoglycemia risk).
- Risk of edema and heart failure - caution required.
- Regular liver function tests (ALT monitoring) required.
Contraindications
Contraindications:
- Patients with established Class III or IV heart failure
Drug interactions
Drug Interactions:
- Glimepiride: Salicylates, sulfonamides, chloramphenicol, clarithromycin, coumarin anticoagulants, probenecid, CYP2C9 inhibitors, fibric acid derivatives, disopyramide, fluoxetine, quinolones, ACE inhibitors, MAOIs and beta-blockers may potentiate hypoglycaemic action
- Rosiglitazone: Gemfibrozil increases plasma concentration; rifampicin decreases
Food interactions
Food Interactions:
- Unsafe to consume alcohol with Glimepiride + Rosiglitazone.
Use in pregnancy
Use in Pregnancy: May be unsafe during pregnancy. Animal studies have shown harmful effects.
Pregnancy Category: C — always consult a doctor before taking during pregnancy.
Use in lactation
Use in Lactation: Probably safe during breastfeeding. Monitor the breastfed baby's blood sugar.
Pediatric use
Pediatric Use: Safety and efficacy in children have not been established.
Geriatric use
Geriatric Use: 1 tab (4mg/1mg) once daily, titrate carefully.
Renal / hepatic impairment
Renal Impairment: 1 tab (4mg/1mg) once daily, titrate carefully. Not recommended in severe kidney disease.
Hepatic Impairment: ALT >2.5x ULN: Do not initiate. ALT >3x ULN or jaundice: Discontinue. Not recommended in severe liver disease.
Overdose effects
Overdose: Severe hypoglycemia with coma, seizure. Administer glucagon or IV glucose. Hypoglycemia may recur - continue monitoring.
Storage conditions
Storage: Store in a cool and dry place. Protect from light and moisture. Keep out of reach of children.
Chemical structure
Glimepiride + Rosiglitazone Tablet